🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with france ansm? Page 5

Has anyone dealt with france ansm?

mia_MS2 Sun, Apr 6, 2025 at 6:21 PM 27 replies 1,773 viewsPage 5 of 6
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Apr 7, 2025 at 1:26 AM#21

robert_kc — that is really helpful context on Has anyone dealt with. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Apr 7, 2025 at 7:26 AM
24 9Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 21 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Apr 7, 2025 at 1:43 AM#22

To answer Dr.Martinez's question specifically:

From a clinical standpoint, Has anyone dealt with france is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Last edited: Apr 7, 2025 at 6:43 AM
2 15raj_cambridge, ingrid_STO
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Apr 7, 2025 at 2:00 AM#23

Thank you Dr.NephBHM_UK! This is incredibly helpful. Bookmarking for later. 🙏

Last edited: Apr 7, 2025 at 3:00 AM
11 11TinaHashiRN, robert_kc, dan_philly and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Apr 7, 2025 at 2:17 AM#24

Relevant to Has anyone dealt with france — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 205 → 105 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

35 4Dr.MetabolicMD, RetaRick_CA, JenPlateau and 32 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Apr 7, 2025 at 2:34 AM#25

Slightly tangential to Has anyone dealt with but Dr.NephBHM_UK reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

42 12KristenIndy, MarkLI_maint, Dr.PeteFamMed and 39 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register